HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

CLINICAL STUDIES OF TOLAZAMIDE AND TOLBUTAMIDE: COMPARATIVE EFFECTIVENESS OF CONTROL OF DIABETES MELLITUS.

Abstract
Tolazamide, a new oral hypoglycemic agent, was compared with tolbutamide, a related chemical compound, for stability of control of 12 patients suffering from maturity-onset diabetes mellitus. A short 12-week study was conducted which incorporated a cross-over design and the results were examined by variance analysis after dosage was individualized to the patient's requirements. Greater stability of fasting blood sugar was found on tolazamide; patients also had less glycosuria and lower fasting blood sugar on tolazamide. Tolazamide appeared to be between five and six times as potent as tolbutamide, mg. for mg.No hepatic, renal, hematologic or symptomatic toxic reactions were observed during the total of 72 person-weeks of tolazamide therapy.
AuthorsC S RENNIE, D O ANDERSON
JournalCanadian Medical Association journal (Can Med Assoc J) Vol. 89 Pg. 669-71 (Sep 28 1963) ISSN: 0008-4409 [Print] Canada
PMID14077815 (Publication Type: Journal Article)
Chemical References
  • Hypoglycemic Agents
  • Tolbutamide
  • Tolazamide
Topics
  • Biomedical Research
  • Diabetes Mellitus, Type 2
  • Glycosuria
  • Humans
  • Hypoglycemic Agents
  • Tolazamide
  • Tolbutamide

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: